AbbVie (ABBV) Receivables (2012 - 2026)
AbbVie (ABBV) reported Receivables of $13.51 billion for Q3 2026, up 5.8% from $12.77 billion a year earlier but down 2.3% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Receivables (2012 - 2026) Analysis & Trends
At the end of FY2025, AbbVie posted Receivables of $12.59 billion, up 15.3% from FY2024.
- Receivables has a five-year compound annual growth rate of 7.4% (FY2020 to FY2025).
- By year, Receivables came in at $10.92 billion in FY2024 (-2.1%), $11.16 billion in FY2023 (-0.9%), $11.25 billion in FY2022 (+12.8%) and $9.98 billion in FY2021 (+13.1%).
- Five-year quarterly Receivables spans a low of $9.98 billion in Q4 2021 and a high of $13.82 billion in Q2 2026.
- Year over year, Receivables gained in six of the last eight quarters, with growth averaging 6.5%.
- The high point for year-over-year Receivables in five years was Q3 2022 (growth of 15.8%); the low point was Q4 2024 (a decline of 2.1%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $13.82 billion (Q2 2026), $12.48 billion (Q1 2026) and $12.59 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 14.33 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 2.31 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 13.51 Bn |
| Jun 30, 2026 | 13.82 Bn |
| Mar 31, 2026 | 12.48 Bn |
| Dec 31, 2025 | 12.59 Bn |
| Sep 30, 2025 | 12.77 Bn |
| Jun 30, 2025 | 12.64 Bn |
| Mar 31, 2025 | 12.48 Bn |
| Dec 31, 2024 | 10.92 Bn |
| Sep 30, 2024 | 11.47 Bn |
| Jun 30, 2024 | 11.72 Bn |
| Mar 31, 2024 | 11.95 Bn |
| Dec 31, 2023 | 11.16 Bn |
| Sep 30, 2023 | 11.41 Bn |
| Jun 30, 2023 | 11.49 Bn |
| Mar 31, 2023 | 11.47 Bn |
| Dec 31, 2022 | 11.25 Bn |
| Sep 30, 2022 | 10.74 Bn |
| Jun 30, 2022 | 11.24 Bn |
| Mar 31, 2022 | 10.73 Bn |
| Dec 31, 2021 | 9.98 Bn |
API Access
AbbVie Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();